Effectiveness, Adverse Events, and Immune Response Following Double Vaccination with BNT162b2 in Staff at the National Comprehensive Cancer Center (NCCC)

Effectiveness, Adverse Events, and Immune Response Following Double Vaccination with BNT162b2 in Staff at the National Comprehensive Cancer Center (NCCC)

Vaccination remains the leading strategy against COVID-19 worldwide. BNT162b2 is among the first licensed vaccines with high effectiveness. However, the role of antibody and cell immunity response monitoring after vaccination remains unclear. We conducted a 6-month prospective study involving the em...

Full description

Bibliographic Details
Main Authors: Patrik Palacka, Monika Pol’anová, Alena Svobodová, Jan Žigmond, Katarína Zanchetta, Vlasta Gombárová, Martina Vulganová, Ján Slopovský, Jana Obertová, Ľuboš Drgoňa, Michal Mego, Juraj Pechan
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Vaccines
Subjects:
BNT162b2
effectiveness
adverse events
IgG antibodies
cell-mediated immunity
Online Access:https://www.mdpi.com/2076-393X/10/4/558

Internet

https://www.mdpi.com/2076-393X/10/4/558

Similar Items